| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/26/2006 | WO2006054666A1 Chick lif protein and utilization thereof |
| 05/26/2006 | WO2006054371A1 Novel ion channel-like polypeptide and use thereof |
| 05/26/2006 | WO2006054297A2 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| 05/26/2006 | WO2006054289A2 Therapeutic implant |
| 05/26/2006 | WO2006054082A1 Process for obtaining antibodies |
| 05/26/2006 | WO2006054063A1 Process for obtaining antibodies |
| 05/26/2006 | WO2006054059A1 Neutralising antibody molecules having specificity for human il-17 |
| 05/26/2006 | WO2006053439A1 Hcv f protein and uses thereof |
| 05/26/2006 | WO2006053380A1 Methods of detecting an analyte in a sample |
| 05/26/2006 | WO2006036213A3 The use of gammaglobulin for the treatment of periodontal disease |
| 05/26/2006 | WO2006033843A3 Lanthanide-based substrates and methods for determining clostridial toxin activity |
| 05/26/2006 | WO2006030318A3 PROTECTIVE ANTI-GLUCAN ANTIBODIES WITH PREFERENCE FOR β-1,3-GLUCANS |
| 05/26/2006 | WO2006018736A3 Use of golden hamster as infectivity model of sars |
| 05/26/2006 | WO2006004660A3 Detection of mutations in a gene associated with resistance to viral infection |
| 05/26/2006 | WO2006003179A3 Antibodies binding to receptors kir2dl1, -2, 3 but not kir2ds4 and their therapeutic use |
| 05/26/2006 | WO2005120557A3 Inhibition of macrophage-stimulating protein receptor (ron) |
| 05/26/2006 | WO2005116658A3 Method for determining a tissue degradation process by detection of comp neoepitopes |
| 05/26/2006 | WO2005115452A3 Fcϝriib-specific antibodies and methods of use thereof |
| 05/26/2006 | WO2005111066A3 Polypeptides from non-typeable haemophilus influenzae |
| 05/26/2006 | WO2005104785A3 Methods and compositions for specifically targeting human hepatocellular carcinoma cells |
| 05/26/2006 | WO2005074633A3 Compositions and methods for characterizing, regulating, diagnosing, and treating cancer |
| 05/26/2006 | WO2004056316A3 Vaccines against hiv-1 tat protein to generate neutralizing antibodies |
| 05/26/2006 | WO2003100007A3 Eta-1 gene and methods for use |
| 05/26/2006 | CA2790433A1 Anti-addl antibodies and uses thereof |
| 05/26/2006 | CA2595673A1 Methods of detecting an analyte in a sample |
| 05/26/2006 | CA2590671A1 Antibodies against vascular endothelial growth factor receptor-1 |
| 05/26/2006 | CA2587903A1 Fully human monoclonal antibodies to il-13 |
| 05/26/2006 | CA2587765A1 Magnetic enrichment of circulating cells, fragments and debris for enabling hts proteomics and genomics in disease detection |
| 05/26/2006 | CA2587716A1 Hcv f protein and uses thereof |
| 05/26/2006 | CA2587627A1 Desacyl ghrelin antibodies and therapeutic uses thereof |
| 05/26/2006 | CA2587597A1 Treatment for inflammatory bowel disorder |
| 05/26/2006 | CA2586615A1 Pro87299 (btla), and variants thereof, for treating immune related disorders |
| 05/26/2006 | CA2584226A1 Process for obtaining antibodies |
| 05/26/2006 | CA2584222A1 Neutralising antibody molecules having specificity for human il-17 |
| 05/26/2006 | CA2582726A1 Process for obtaining antibodies |
| 05/25/2006 | WO2006037038A9 Optimized vaccines to provide protection against ebola and other viruses |
| 05/25/2006 | US20060111562 Human SDF-5 protein and compositions |
| 05/25/2006 | US20060111561 Novel proteins and nucleic acids encoded thereby |
| 05/25/2006 | US20060111559 Human G-Protein Chemokine Receptor (CCR5) HDGNR10 |
| 05/25/2006 | US20060111556 Preventives/remedies for neurodegenerative diseases |
| 05/25/2006 | US20060111551 Peptide having HTLV-1-specific CTL-inducing activity |
| 05/25/2006 | US20060111297 Blood factor domains |
| 05/25/2006 | US20060111290 Stromal-Derived Factor-1 (SDF), G-CSF (granulocyte-colony stimulating factor), stimulating vasculogenesis; improves cardiac function |
| 05/25/2006 | US20060111287 Acetylated protein |
| 05/25/2006 | US20060110803 Antigenic peptides of SARS coronavirus and uses thereof |
| 05/25/2006 | US20060110802 DNA encoding novel 4-1BB ligand (4-1BB-L) polypeptides which are members of the tumor necrosis factor (TNF) receptor super-family; expression vectors and antibodies; use to stimulate proliferation of activated T-cells for immunotherapy |
| 05/25/2006 | US20060110800 Testis-specific receptor |
| 05/25/2006 | US20060110793 Methods and compositions for increasing longevity and protein yield from a cell culture |
| 05/25/2006 | US20060110776 Monoclonal antibodies for binding to native proBNP to diagnose heart failure and hybridomas to produce antibodies |
| 05/25/2006 | US20060110775 Monoclonal antibodies for binding to native proBNP to diagnose heart failure and hybridomas to produce antibodies |
| 05/25/2006 | US20060110774 Methods for detecting sepsis |
| 05/25/2006 | US20060110772 Human and murine cytokine polypeptides |
| 05/25/2006 | US20060110771 Proteins capable of binding to female sex hormones and process for producing the same |
| 05/25/2006 | US20060110737 Human tumor-associated gene ct120 on chromosome 17p 13.3 region and the protein encoded by it |
| 05/25/2006 | US20060110734 conducting a bioassay on a DNA sample or an RNA sample, to determine the presence or absence of gene mutations associated with a genetic disorder with clinical features including exocrine pancreatic insufficiency, haematological dysfunction and skeletal abnormalities |
| 05/25/2006 | US20060110731 Cancer-linked gene as target for chemotherapy |
| 05/25/2006 | US20060110407 Immune globulin formulations for the treatment and prevention of an orthopoxvirus infection |
| 05/25/2006 | US20060110395 Use of CRKD as a breast cancer marker and cancer therapy target |
| 05/25/2006 | US20060110394 Bind to alpha-4 integrin; asthma, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, transplant rejection, graft versus host disease, tumor metastasis, nephritis, atopic dermatitis, psoriasis, myocardial ischemia, acute leukocyte mediated lung injury |
| 05/25/2006 | US20060110393 Novel proteins and use thereof |
| 05/25/2006 | US20060110392 Murine monoclonal antibody (5c8) recognizes T-B cell activating molecule (T-BAM) (CD40 LIGAND) on the surface of T-lymphocytes, compositions containing same and methods of use |
| 05/25/2006 | US20060110389 Method of treatment using anti-IL-18 antibody |
| 05/25/2006 | US20060110388 ß binding molecules |
| 05/25/2006 | US20060110385 Means and methods for diagnosing and treating affective disorders |
| 05/25/2006 | US20060110384 Novel proteins and use thereof |
| 05/25/2006 | US20060110382 For treating a disease medicated by TNF alpha including acute and chronic immune and immunoregulatory disorders and rheumatoid or osteo-arthritis |
| 05/25/2006 | US20060110324 Human anti-epidermal growth factor receptor single-chain antibodies |
| 05/24/2006 | EP1659406A1 Method for the detection and direct measurement of macroprolactines and/or prolactines |
| 05/24/2006 | EP1659177A2 Secreted and transmembrane polypeptides and nucleic acids ancoding the same |
| 05/24/2006 | EP1659133A2 Human-murine chimeric antibodies against respiratory syncytial virus |
| 05/24/2006 | EP1659131A2 Polypeptides and nucleic acids encoding the same |
| 05/24/2006 | EP1658859A1 APO-2L receptor agonist and CPT-11 synergism |
| 05/24/2006 | EP1658506A2 Methods for reducing complexity of a sample using small epitope antibodies |
| 05/24/2006 | EP1658500A1 Methods for obtaining antibodies |
| 05/24/2006 | EP1658498A1 Methods for obtaining antibodies |
| 05/24/2006 | EP1658248A1 Method for the production of porous carbon-based molded bodies, and use thereof as cell culture carrier systems and culture systems |
| 05/24/2006 | EP1658096A1 Method of inducing immune tolerance |
| 05/24/2006 | EP1658095A1 De-immunized anti-cd3 antibody |
| 05/24/2006 | EP1658037A2 Method of treatment and bioassay involving macrophage migration inhibitory factor (mif) as cardiac-derived myocardial depressant factor |
| 05/24/2006 | EP1658036A2 Estrogen receptor modulators and uses thereof |
| 05/24/2006 | EP1423418B1 Mutated env gene, mutated env glycoprotein and the use thereof |
| 05/24/2006 | EP1419277B1 Isolation of membrane bound ligand-specific complexes |
| 05/24/2006 | EP1322383B1 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 05/24/2006 | EP1212410B1 Dna encoding the human serine protease eos |
| 05/24/2006 | EP1141305B1 Chimeric gene encoding the antigenic determinants of four proteins of l. infantum |
| 05/24/2006 | EP1071443B1 Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof |
| 05/24/2006 | EP1015585B1 Tie ligand homologues |
| 05/24/2006 | EP1002075B1 Adipocyte-specific protein homologs |
| 05/24/2006 | EP0907733B1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 05/24/2006 | EP0892809B1 Fhit proteins and nucleic acids and methods based thereon |
| 05/24/2006 | EP0872488B1 MONOCLONAL ANTIBODY REACTING SPECIFICALLY WITH Fas LIGAND AND PROCESS FOR PRODUCING THE SAME |
| 05/24/2006 | EP0746613B1 Recombinant humanized anti-fb5 antibodies |
| 05/24/2006 | CN1777810A A method for the in vitro assessment of the progression status of an infection by an HIV virus in an individual |
| 05/24/2006 | CN1777680A Methods of inducing the expression of bone morphogenetic proteins (BMPs) and transforming growth factor-beta-proteins (TGF-ª‰s) in cells |
| 05/24/2006 | CN1777676A Schizophrenia-related voltage-gated ion channel gene and protein |
| 05/24/2006 | CN1777672A Recombinant virus comprising tumour therapeutic full-antibody gene with human constant region and its use |
| 05/24/2006 | CN1777622A Modulation of the poliovirus receptor function |
| 05/24/2006 | CN1777621A Antibodies against human il-21 receptor and applications therefor |
| 05/24/2006 | CN1777444A Compositions and methods for the therapy of inflammatory bowel disease |
| 05/24/2006 | CN1777443A Methods of diagnosing and treating pre-eclampsia or eclampsia |